作者: Qingying Luo , Yang Li , Jianjun Deng , Zunzhen Zhang
DOI: 10.1016/J.CBI.2014.12.007
关键词:
摘要: Arsenic trioxide (ATO) is successfully used to treat hematological malignancies. However, the clinical application of the agent in solid tumors is largely limited by its dose-dependent …